SHINE closes $80m Series C round
2 September 2020
Lead investors: Fidelity Management and Research Company
Fusion approach: Beam-target Fusion, Inertial Confinement
Country/Region: USA
Tags: SHINE Medical Technologies, SHINE Technologies, SHINE Therapeutics

